190 related articles for article (PubMed ID: 34712948)
1. Digitalization in pharmaceutical industry: What to focus on under the digital implementation process?
Hole G; Hole AS; McFalone-Shaw I
Int J Pharm X; 2021 Dec; 3():100095. PubMed ID: 34712948
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical Manufacturing in the EU and the EU-US Mutual Recognition Agreement.
Gaspar Ernesto LM; Dias Loureiro RM
PDA J Pharm Sci Technol; 2020; 74(6):617-626. PubMed ID: 32540862
[TBL] [Abstract][Full Text] [Related]
3. CDMOs Play a Critical Role in the Biopharmaceutical Ecosystem.
Kurata H; Ishino T; Ohshima Y; Yohda M
Front Bioeng Biotechnol; 2022; 10():841420. PubMed ID: 35387299
[TBL] [Abstract][Full Text] [Related]
4. Fighting trafficking of falsified and substandard medicinal products in Russia.
Fayzrakhmanov NF
Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
[TBL] [Abstract][Full Text] [Related]
5. Assessing the level of digitalization and robotization in the enterprises of the European Union Member States.
Brodny J; Tutak M
PLoS One; 2021; 16(7):e0254993. PubMed ID: 34293023
[TBL] [Abstract][Full Text] [Related]
6. Robotics and Aseptic Processing in View of Regulatory Requirements.
Tanzini A; Ruggeri M; Bianchi E; Valentino C; Vigani B; Ferrari F; Rossi S; Giberti H; Sandri G
Pharmaceutics; 2023 May; 15(6):. PubMed ID: 37376030
[TBL] [Abstract][Full Text] [Related]
7. The Minderoo-Monaco Commission on Plastics and Human Health.
Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
[TBL] [Abstract][Full Text] [Related]
8. Descriptive Analysis of Good Clinical Practice Inspection Findings from U.S. Food and Drug Administration and European Medicines Agency.
Sellers JW; Mihaescu CM; Ayalew K; Kronstein PD; Yu B; Ning YM; Rodriguez M; Williams L; Khin NA
Ther Innov Regul Sci; 2022 Sep; 56(5):753-764. PubMed ID: 35610469
[TBL] [Abstract][Full Text] [Related]
9. Advancing non-destructive analysis of 3D printed medicines.
Jørgensen AK; Ong JJ; Parhizkar M; Goyanes A; Basit AW
Trends Pharmacol Sci; 2023 Jun; 44(6):379-393. PubMed ID: 37100732
[TBL] [Abstract][Full Text] [Related]
10. Launching a CDMO in Brazil aiming to develop biopharmaceuticals for clinical trials.
Ferreira RS; Morales MM; Barretti P; Barraviera B
J Venom Anim Toxins Incl Trop Dis; 2022; 28():e20220017. PubMed ID: 35721790
[TBL] [Abstract][Full Text] [Related]
11. [Study of intelligent manufacturing quality digitalization of traditional Chinese medicine and practice on Compound Danshen Dripping Pills].
Xiong HS; Zhang SN; Zhu YH; Yan XJ; Ye ZL; Yan KJ; Qu HB
Zhongguo Zhong Yao Za Zhi; 2020 Apr; 45(7):1698-1706. PubMed ID: 32489052
[TBL] [Abstract][Full Text] [Related]
12. Opportunities for healthcare digitalization in Europe: Comparative analysis of inequalities in access to medical services.
Majcherek D; Hegerty SW; Kowalski AM; Lewandowska MS; Dikova D
Health Policy; 2024 Jan; 139():104950. PubMed ID: 38061175
[TBL] [Abstract][Full Text] [Related]
13. [Chinese medicine industry 4.0：advancing digital pharmaceutical manufacture toward intelligent pharmaceutical manufacture].
Cheng YY; Qu HB; Zhang BL
Zhongguo Zhong Yao Za Zhi; 2016 Jan; 41(1):1-5. PubMed ID: 28845630
[TBL] [Abstract][Full Text] [Related]
14. The Utility of Remote Inspections During the COVID-19 Health Emergency and in the Postpandemic Setting.
Mofid S; Bolislis WR; Brading C; Hamilton N; Hardit C; Nagaoka M; Parain J; Zanta M; Kühler TC
Clin Ther; 2021 Dec; 43(12):2046-2063. PubMed ID: 34740466
[TBL] [Abstract][Full Text] [Related]
15. Decarbonization in waste recycling industry using digitalization to promote net-zero emissions and its implications on sustainability.
Kurniawan TA; Othman MHD; Liang X; Goh HH; Gikas P; Kusworo TD; Anouzla A; Chew KW
J Environ Manage; 2023 Jul; 338():117765. PubMed ID: 36965421
[TBL] [Abstract][Full Text] [Related]
16. Data Management in a Regulatory Context.
Grønning N
Front Med (Lausanne); 2017; 4():114. PubMed ID: 28785556
[TBL] [Abstract][Full Text] [Related]
17. Transparent collaboration between industry and academia can serve unmet patient need and contribute to reproductive public health.
D'Hooghe T
Hum Reprod; 2017 Aug; 32(8):1549-1555. PubMed ID: 28854594
[TBL] [Abstract][Full Text] [Related]
18. Drugs and Devices: Comparison of European and U.S. Approval Processes.
Van Norman GA
JACC Basic Transl Sci; 2016 Aug; 1(5):399-412. PubMed ID: 30167527
[TBL] [Abstract][Full Text] [Related]
19. An integrated data management and informatics framework for continuous drug product manufacturing processes: A case study on two pilot plants.
Chen Y; Sampat C; Huang YS; Ganesh S; Singh R; Ramachandran R; Reklaitis GV; Ierapetritou M
Int J Pharm; 2023 Jul; 642():123086. PubMed ID: 37257793
[TBL] [Abstract][Full Text] [Related]
20. Institutional barriers and enablers to implementing and complying with internationally accepted quality standards in the local pharmaceutical industry of Pakistan: a qualitative study.
Tauqeer F; Myhr K; Gopinathan U
Health Policy Plan; 2019 Jul; 34(6):440-449. PubMed ID: 31302684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
